• Explore /
  • Poster
  • / Association of on-treatment plasma HGF levels with overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (INF) +/- bevacizumab (BEV): Results from CALGB 90206 (Alliance).

Association of on-treatment plasma HGF levels with overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (INF) +/- bevacizumab (BEV): Results from CALGB 90206 (Alliance).

Abstract Poster

Authors

Daniel George

Daniel J. George

Duke Cancer Institute, Duke University Medical Center, Durham, NC

Daniel J. George , Susan Halabi , Mark D. Starr , Herbert Hurwitz , John C. Brady , Ian Barak , Michael J. Morris , Brian I. Rini , Eric Jay Small , Won Kim , Mary-Ellen Taplin , Andrew B. Nixon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Citation

J Clin Oncol 35, 2017 (suppl; abstr 4522)

DOI

10.1200/JCO.2017.35.15_suppl.4522

Abstract #

4522

Poster Bd #

200

Abstract Disclosures

Similar Posters

First Author: Harriet M. Kluger

First Author: Andrew B. Nixon

First Author: Tomoyuki Kato

First Author: Elaine Chang